Development of an antidiabetic formulation (ADJ6) and its inhibitory activity against α-amylase and α-glucosidase

Journal of Traditional and Complementary Medicine

Volumn 6, Issue 3, 2016, Pages 204-208

  Duraiswamy, Anand ^a   Shanmugasundaram, Devanand ^a   Sasikumar, Changam Sheela ^a   Cherian, Sanjay M ^b   Cherian, Kotturathu Mammen ^b  

^a UNIVERSITY OF MADRAS   (India)

^b Frontier Lifeline Hospital   (India)

Author keywords

ADJ6; diabetes management; polyherbal formulation; amylase; glucosidase

Indexed keywords

EID: 84977271275     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/j.jtcme.2014.12.006     Document Type: Article

References (62)

1. 1 Rorsman, P., Review: insulin secretion: function and therapy of pancreatic beta-cells in diabetes. Br J Diabetes Vasc Dis 5 (2005), 187–191.
2. 2 Pfeifer, M.A., Halter, J.B., Porte, D. Jr., Insulin secretion in diabetes mellitus. Am J Med 70 (1981), 579–588.
3. 3 Kahn, S.E., Hull, R.L., Utzschneider, K.M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006), 840–846.
4. 4 Schwartz, M.S., Chadha, A., Type 2 diabetes mellitus in childhood: obesity and insulin resistance. J Am Osteopath Assoc 108 (2008), 518–524.
5. 5 Blonde, L., Current challenges in diabetes management. Clin Cornerstone 7:suppl 3 (2005), S6–S17.
6. 6 Venkataraman, K., Kannan, A.T., Mohan, V., Challenges in diabetes management with particular reference to India. Int J Diabetes Dev Ctries 29 (2009), 103–109.
7. 7 Brown, M.T., LeRoth, D., Overcoming challenges in type 2 diabetes management to improve patient outcomes. Expert Rev Endocrinol Metab 5 (2010), 741–751.
8. 8 Kennedy, M., Roberts, A., Complex type 2 diabetes mellitus—management challenges and pitfalls. Aust Fam Physician 42 (2013), 207–210.
9. 9 Grover, J.K., Yadav, S., Vats, V., Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 81 (2002), 81–100.
10. 10 Modak, M., Dixit, P., Londhe, J., Ghaskadbi, S., Devasagayam, T.P., Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 40 (2007), 163–173.
11. 11 Khan, V., Najmi, A.K., Akhtar, M., Aqil, M., Mujeeb, M., Pillai, K.K., A pharmacological appraisal of medicinal plants with antidiabetic potential. J Pharm Bioallied Sci 4 (2012), 27–42.
12. 12 Ahmed, I., Adeghate, E., Sharma, A.K., Pallot, D.J., Singh, J., Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract 40 (1998), 145–151.
13. 13 Gürbüz, I., Akyüz, C., Yeşilada, E., Sener, B., Anti-ulcerogenic effect of Momordica charantia L. fruits on various ulcer models in rats. J Ethnopharmacol 71 (2000), 77–82.
14. 14 Ahmed, I., Lakhani, M.S., Gillett, M., John, A., Raza, H., Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 51 (2001), 155–161.
15. 15 Mishra, L.C., Scientific Basis for Ayurvedic Therapies. 2003, CRC Press LLC, 2000 N.W. Corporate Blvd., Boca Raton, Florida 33431, USA.
16. 16 Virdi, J., Sivakami, S., Shahani, S., Suthar, A.C., Banavalikar, M.M., Biyani, M.K., Antihyperglycemic effects of three extracts from Momordica charantia. J Ethnopharmacol 88 (2003), 107–111.
17. 17 Prasad, V., Jain, V., Girish, D., Dorle, A.K., Wound-healing property of Momordica charantia L. fruit powder. J Herb Pharmacother 6 (2006), 105–115.
18. 18 Patel, R., Mahobia, N., Upwar, N., Waseem, N., Talaviya, H., Patel, Z., Analgesic and antipyretic activities of Momordica charantia Linn. fruits. J Adv Pharm Technol Res 1 (2010), 415–418.
19. 19 Hsiao, P.C., Liaw, C.C., Hwang, S.Y., et al. Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia. J Agric Food Chem 61 (2013), 2979–2986.
20. 20 Jiménez-Escrig, A., Rincón, M., Pulido, R., Saura-Calixto, F., Guava fruit (Psidium guajava L.) as a new source of antioxidant dietary fiber. J Agric Food Chem 49 (2001), 5489–5493.
21. 21 Gutiérrez, R.M., Mitchell, S., Solis, R.V., Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 117 (2008), 1–27.
22. 22 Rai, P.K., Jaiswal, D., Mehta, S., Watal, G., Anti-hyperglycaemic potential of Psidium guajava raw fruit peel. Indian J Med Res 129 (2009), 561–565.
23. 23 Rai, P.K., Mehta, S., Watal, G., Hypolipidaemic and hepatoprotective effects of Psidium guajava raw fruit peel in experimental diabetes. Indian J Med Res 131 (2010), 820–824.
24. 24 Lin, C.Y., Yin, M.C., Renal protective effects of extracts from guava fruit (Psidium guajava L.) in diabetic mice. Plant Foods Hum Nutr 67 (2012), 303–308.
25. 25 Ihantola-Vormisto, A., Summanen, J., Kankaanranta, H., Vuorela, H., Asmawi, Z.M., Moilanen, E., Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 63 (1997), 518–524.
26. 26 Sumantran, V.N., Kulkarni, A., Chandwaskar, R., et al. Chondroprotective potential of fruit extracts of Phyllanthus emblica in osteoarthritis. Evid Based Complement Alternat Med 5 (2008), 329–335.
27. 27 Krishnaveni, M., Mirunalini, S., Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. J Basic Clin Physiol Pharmacol 21 (2010), 93–105.
28. 28 Akhtar, M.S., Ramzan, A., Ali, A., Ahmad, M., Effect of amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr 62 (2011), 609–616.
29. 29 Usharani, P., Fatima, N., Muralidhar, N., Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes 6 (2013), 275–284.
30. 30 Bin-Hafeez, B., Haque, R., Parvez, S., Pandey, S., Sayeed, I., Raisuddin, S., Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice. Int Immunopharmacol 3 (2003), 257–265.
31. 31 Tripathi, U.N., Chandra, D., The plant extracts of Momordica charantia and Trigonella foenum-graecum have anti-oxidant and anti-hyperglycemic properties for cardiac tissue during diabetes mellitus. Oxid Med Cell Longev 2 (2009), 290–296.
32. 32 Moorthy, R., Prabhu, K.M., Murthy, P.S., Anti-hyperglycemic compound (GII) from fenugreek (Trigonella foenum-graecum Linn.) seeds, its purification and effect in diabetes mellitus. Indian J Exp Biol 48 (2010), 1111–1118.
33. 33 Kumar, P., Kale, R.K., McLean, P., Baquer, N.Z., Antidiabetic and neuroprotective effects of Trigonella foenum-graecum seed powder in diabetic rat brain. Prague Med Rep 113 (2012), 33–43.
34. 34 Prince, P.S., Menon, V.P., Pari, L., Hypoglycaemic activity of Syzigium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. J Ethnopharmacol 61 (1998), 1–7.
35. 35 Prince, P.S.M., Kamalakkannan, N., Menon, V.P., Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain. J Ethnopharmacol 84:2–3 (2003), 205–209.
36. 36 Kochhar, A., Nagi, M., Effect of supplementation of traditional medicinal plants on blood glucose in non-insulin-dependent diabetics: a pilot study. J Med Food 8 (2005), 545–549.
37. 37 Arun, R., Prakash, M.V., Abraham, S.K., Premkumar, K., Role of Syzygium cumini seed extract in the chemoprevention of in vivo genomic damage and oxidative stress. J Ethnopharmacol 134 (2011), 329–333.
38. 38 Aqil, F., Gupta, A., Munagala, R., et al. Antioxidant and antiproliferative activities of anthocyanin/ellagitannin-enriched extracts from Syzygium cumini L. Nutr Cancer 64 (2012), 428–438.
39. 39 Baskaran, K., Kizar Ahamath, B., Radha Shanmugasundaram, K., Shanmugasundaram, E.R., Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol 30 (1990), 295–300.
40. 40 Kanetkar, P., Singhal, R., Kamat, M., Gymnema sylvestre: a memoir. J Clin Biochem Nutr 41 (2007), 77–81.
41. 41 Arun, L.B., Arunachalam, A.M., Arunachalam, K.D., Annamalai, S.K., Kumar, K.A., In vivo anti-ulcer, anti-stress, anti-allergic, and functional properties of gymnemic acid isolated from Gymnema sylvestre R Br. BMC Complement Altern Med, 14, 2014, 70.
42. 42 Yadav, M., Lavania, A., Tomar, R., Prasad, G.B., Jain, S., Yadav, H., Complementary and comparative study on hypoglycemic and antihyperglycemic activity of various extracts of Eugenia jambolana seed, Momordica charantia fruits, Gymnema sylvestre, and Trigonella foenum graecum seeds in rats. Appl Biochem Biotechnol 160 (2010), 2388–2400.
43. 43 Miller, G.L., Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem 31 (1959), 426–428.
44. 44 Kim, Y.M., Jeong, Y.K., Wang, M.H., Lee, W.Y., Rhee, H.I., Inhibitory effect of pine extract on alpha-glucosidase activity and postprandial hyperglycemia. Nutrition 21 (2005), 756–761.
45. 45 Trease, G.E., Evans, W.C., A Textbook of Pharmacognosy. 1989, London, Academic Press, 22–40.
46. 46 McDonald, S., Prenzler, P.D., Antolovich, M., Robards, K., Phenolic content and antioxidant activity of olive extracts. Food Chem 73 (2001), 73–84.
47. 47 Cameron, G.R., Milton, R.F., Allan, J.W., Measurement of flavonoids in plant sample. Lancet, 179, 1943.
48. 48 Roe, J.H., Comparative analyses for ascorbic acid by the 2,4-dinitrophenylhydrazine method with the coupling reaction at different temperatures: a procedure for determining specificity. J Biol Chem 236 (1961), 1611–1613.
49. 49 Eichler, H.G., Korn, A., Gasic, S., Pirson, W., Businger, J., The effect of a new specific α-amylase inhibitor on post-prandial glucose and insulin excursions in normal subjects and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 26 (1984), 278–281.
50. 50 Chiba, S., Molecular mechanism in alpha-glucosidase and glucoamylase. Biosci Biotechnol Biochem 61 (1997), 1233–1239.
51. 51 Kast, R.E., Acarbose related diarrhea: increased butyrate upregulates prostaglandin E. Inflamm Res 51 (2002), 117–118.
52. 52 Andrade, R.J., Lucena, M., Vega, J.L., et al. Acarbose-associated hepatotoxicity. Diabetes Care 21 (1998), 2029–2030.
53. 53 Diaz-Gutierrez, F.L., Ladero, J.M., Diaz-Rubio, M., Acarbose-induced acute hepatitis. Am J Gastroenterol, 93, 1998, 481.
54. 54 Fujimoto, Y., Ohhira, M., Miyokawa, N., Kitamori, S., Kohgo, Y., Acarbose-induced hepatic injury. Lancet, 351, 1998, 340.
55. 55 Gentile, S., Turco, S., Guarino, G., Sasso, F.C., Torella, R., Aminotransferase activity and acarbose treatment in patients with type 2 diabetes. Diabetes Care 22 (1998), 1217–1218.
56. 56 Sharma, S.C., Ahmad, S.A., Traditional medicinal plants: ancient and modern approach. Anc Sci Life 12 (1992), 197–200.
57. 57 Matsuda, H., Morikawa, T., Yoshika, M., Antidiabetogenic constituents from several natural medicines. Pure Appl Chem 74 (2002), 1301–1308.
58. 58 Vaidya, A.D., Devasagayam, T.P., Current status of herbal drugs in India: an overview. J Clin Biochem Nutr 41 (2007), 1–11.
59. 59 Harbilas, D., Martineau, L.C., Harris, C.S., et al. Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part II. Can J Physiol Pharmacol 87 (2009), 479–492.
60. 60 Petrovska, B.B., Historical review of medicinal plants' usage. Pharmacogn Rev 6 (2012), 1–5.
61. 61 Mahomoodally, M.F., Traditional medicines in Africa: an appraisal of ten potent African medicinal plants. Evid Based Complement Alternat Med, 2013, 2013, 14.
62. 62 Apostolidis, E., Kwon, Y.I., Shetty, K., Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov Food Sci Emerg Technol 8 (2007), 46–54.